EnPlusOne Biosciences, a biotechnology company harnessing the power of enzymes to deliver better RNA at scale, announced the appointment of Clare Murray, Ph.D., as...
EveryONE Medicines, a company pioneering a scalable, global framework to design, develop, and manufacture individualized medicines for children with life-threatening neurodegenerative diseases, announced the...
AIRNA, a biotech company pioneering RNA editing therapeutics to transform the lives of patients with rare and common conditions, announced the appointment of Jacob...
Wayfinder Biosciences, a biotechnology company targeting RNA with small molecules, announced a collaboration with Daiichi Sankyo focused on a key neurodegeneration target.
Wayfinder's proprietary technology...
Boehringer Ingelheim and Cue Biopharma, announced a strategic research collaboration and license agreement to develop and commercialize Cue Biopharma’s CUE-501 product candidate, a differentiated B...
